Type 2 diabetes mellitus patient profiles, diseases control and complications at four public health facilities- A cross-sectional study based on the Adult Diabetes Control and Management (ADCM) registry 2009

Medical Journal of Malaysia

Volumn 68, Issue 5, 2013, Pages 397-404

  Chew, B H ^a   Shariff Ghazali, S ^a   Lee, P Y ^a   Cheong, A T ^a   Mastura, I ^b   Haniff, J ^c   Bujang, M A ^c   Taher, S W ^d   Mustapha, F I ^e  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Seremban Primary Health Clinic   (Malaysia)

^c HOSPITAL KUALA LUMPUR   (Malaysia)

^d Bandar Sungai Petani Health Clinic   (Malaysia)

^e MINISTRY OF HEALTH   (Malaysia)

Author keywords

Cardiovascular diseases; Diabetes complications; Disease management; Health facilities; Type 2 diabetes mellitus

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; AMPUTATION; ARTICLE; BODY MASS; CEREBROVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; DYSLIPIDEMIA; FEMALE; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MICROALBUMINURIA; MIDDLE AGED; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PROTEINURIA; PUBLIC HEALTH SERVICE; PUBLIC HOSPITAL; RETINOPATHY; SYSTOLIC BLOOD PRESSURE; YOUNG ADULT;

EID: 84895884354     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Omar M, Tong SF, Saleh N, et al. A comparison of morbidity patterns in public and private primary care clinics in Malaysia. Malaysian Family Physician 2011; 6(1): 19-25.
2. Teng CL, Aljunid SM, Cheah M, Leong KC, Kwa SK. Morbidity and process of care in urban Malaysian general practice: the impact of payment system. Med J Malaysia 2003; 58(3): 365-74.
3. Ministry of Health, Malaysia. National Health Morbidity Survey III. Putrajaya; 2006.
4. Ministry of Health, Malaysia. National Health Morbidity Survey IV. Putrajaya; 2012.
5. Cherry DK, Hing E, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2006 summary. Natl Health Stat Report 2008(3): 1- 39.
6. Pierce M, Agarwal G, Ridout D. A survey of diabetes care in general practice in England and Wales. Br J Gen Pract 2000; 50(456): 542-5.
7. Wee SL, Tan CG, Ng HS, et al. Diabetes outcomes in specialist and general practitioner settings in Singapore: challenges of right-siting. Ann Acad Med Singapore 2008; 37(11): 929-35.
8. Ismail H, Wright J, Rhodes P, Scally A. Quality of care in diabetic patients attending routine primary care clinics compared with those attending GP specialist clinics. Diabet Med 2006; 23(8): 851-6.
9. Toh MP, Heng BH, Sum CF, Jong M, Chionh SB, Cheah JT. Measuring the quality of care of diabetic patients at the specialist outpatient clinics in public hospitals in Singapore. Ann Acad Med Singapore 2007; 36(12): 980- 6.
10. Greenfield S, Rogers W, Mangotich M, Carney MF, Tarlov AR. Outcomes of patients with hypertension and non-insulin dependent diabetes mellitus treated by different systems and specialties. Results from the medical outcomes study. JAMA 1995; 274(18): 1436-44.
11. De Berardis G, Pellegrini F, Franciosi M, et al. Quality of care and outcomes in type 2 diabetic patients: a comparison between general practice and diabetes clinics. Diabetes Care 2004; 27(2): 398-406.
12. Greenfield S, Kaplan SH, Kahn R, Ninomiya J, Griffith JL. Profiling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results. Ann Intern Med 2002; 136(2): 111-21.
13. Mastura I, Chew BH, Lee PY, et al. Control and Treatment Profiles of 70,889 Adult Type 2 Diabetes Mellitus Patients in Malaysia. International Journal of Collaborative Research on Internal Medicine & Public Health 2011; 3(1): 98-113.
14. Awin N. A Review of Primary Health Care in Malaysia- A Report for the World Health Organization Western Pacific Region. Ministry of Health, Malaysia, 2001.
15. Chew BH, Mastura I, Shariff-Ghazali S, et al. Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009. Cardiovasc Diabetol 2012; 11(1): 54.
16. WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation; 1999. Report no. 99.2.
17. Ministry of Health, Malaysia. Management of Type 2 Diabetes Mellitus. putrajaya: Technology, Health Section, Assessment Division, Medical Development; 2009.
18. Standards of Medical Care in Diabetes-2012. Diabetes Care 2012; 35(Supplement 1): S11-S63.
19. Ministry of Health, Malaysia. Health Technology Assessment Unit. Clinical Practice Guidelines- Management of Hypertension. Expert review of cardiovascular therapy. Putrajaya; 2008.
20. Chew BH, Ismail M, Lee PY, et al. Determinants of uncontrolled dyslipidaemia among adult type 2 diabetes in Malaysia: The Malaysian Diabetes Registry 2009. Diabetes Res Clin Pract 2012; 96: 339-47.
21. Lee PY, Cheong AT, Zaiton A, et al. Does Ethnicity Contribute to the Control of Cardiovascular Risk Factors Among Patients With Type 2 Diabetes? Asia Pac J Public Health 2011.[In Press]
22. Y H Chan. Biostatistics 202: Logistic regression analysis. Singapore Med J 2004; 45(4): 149-153.
23. Tai TY, Chuang LM, Tsai ST, Huang BY, Diabcare Study G. Treatment of type 2 diabetes mellitus in a primary care setting in Taiwan: comparison with secondary/tertiary care. J Formos Med Assoc 2006; 105(2): 105-17.
24. Arai K, Hirao K, Matsuba I, et al. The status of glycemic control by general practitioners and specialists for diabetes in Japan: a cross-sectional survey of 15,652 patients with diabetes mellitus. Diabetes Res Clin Pract 2009; 83(3): 397-401.
25. Jaakko T. Impact of age on cardiovascular risk: implications for cardiovascular disease management. Atheroscler Suppl 2004; 5(2): 9-17.
26. Hubert K, Berthold S, Lutz H, et al. Type 2 diabetes phenotype and progression is significantly different if diagnosed before versus after 65 years of age. J Diabetes Sci Technol 2008; 2(1): 82-90.
27. George D. Early and Intensive Therapy for Management of Hyperglycemia and Cardiovascular Risk Factors in Patients With Type 2 Diabetes. Clin Ther 2011; 33(6): 665-78.
28. Soe K, Sacerdote A, Karam J, Bahtiyar G. Management of type 2 diabetes mellitus in the elderly. Maturitas 2011; 70(2): 151-9.
29. Bi Y, Zhu D, Cheng J, et al. The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China. Clin Ther 2010; 32(5): 973-83.
30. Peyrot M, Rubin RR, Lauritzen T, et al. Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study. Diabetologia 2006; 49(2): 279-88.
31. Parchman ML, Zeber JE, Palmer RF. Participatory Decision Making, Patient Activation, Medication Adherence, and Intermediate Clinical Outcomes in Type 2 Diabetes: A STARNet Study. Ann Fam Med 2010; 8(5): 410-7.
32. Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009; 32(1): 187-92.
33. Marshall SM. Intensive diabetes management for high-risk patients: how best to deliver? Diabetes Care 2009; 32: 1132-3.
34. Monica O, Stephen L, Dan C, Shanthi M. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ 2012; 344.
35. CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes. JAMA 2002; 287(19): 2542-51.
36. Pawaskar M, Li Q, Reynolds MW. Metabolic outcomes of elderly patient populations initiating exenatide BID versus insulin glargine in an ambulatory care setting. Curr Med Res Opin 2012; 28: 991-7.
37. Han S, Iglay K, Davies MJ, Zhang Q, Radican L. Glycemic effectiveness and medication adherence with fixed-dose combination or coadministered dual therapy of antihyperglycemic regimens: a meta-analysis. Curr Med Res Opin 2012; 28: 969-77.
38. Brownson CA, Hoerger TJ, Fisher EB, Kilpatrick KE. Cost-effectiveness of Diabetes Self-management Programs in Community Primary Care Settings. Diabetes Educ 2009; 35(5): 761-9.
39. White RD. Patient empowerment and optimal glycemic control. Curr Med Res Opin 2012; 28: 979-89.
40. Khunti K, Gray LJ, Skinner T, et al. Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. BMJ 2012; 344: e2333.
41. Wolf AM, Siadaty M, Yaeger B, et al. Effects of lifestyle intervention on health care costs: Improving Control with Activity and Nutrition (ICAN). J Am Diet Assoc 2007; 107(8): 1365-73.